poisar

Stock

10x Genomics, Inc. TXG

$64.84+0.89%

Overview

TXG market data

Price History

TXG price chart · 1M
O
63.88
H
65.61
L
63.88
C
64.84
Vol
115,829.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$63.88
Previous Close
$64.27
Day High
$65.61
Day Low
$63.88
52 Week High
$66.91
52 Week Low
$19.54
7 Day Return
+1.51%
30 Day Return
+37.90%
90 Day Return
+128.87%
1 Year Return
+220.99%
Daily Notional Volume
$7.5M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.35
Diluted earnings per share over the trailing twelve months.
Beta
2.07
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-12.2%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$11.16 – $66.94
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $7.6B · P/B 2.59 · P/S 12.32.

Company News

10 captured
Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On WednesdayBenzinga · Aug 19, 2026, 2:08 PM
Stephens & Co. Maintains Overweight on 10x Genomics, Raises Price Target to $65Benzinga · Aug 12, 2026, 4:21 PM
Piper Sandler Maintains Neutral on 10x Genomics, Raises Price Target to $47Benzinga · Aug 10, 2026, 6:37 PM
10x Genomics shares are trading higher after Canaccord raised its price target on the stock from $50 to $60.Benzinga · Aug 10, 2026, 2:59 PM
Canaccord Genuity Maintains Buy on 10x Genomics, Raises Price Target to $60Benzinga · Aug 10, 2026, 12:01 PM
Citigroup Maintains Neutral on 10x Genomics, Raises Price Target to $50Benzinga · Aug 7, 2026, 8:19 PM
Morgan Stanley Maintains Equal-Weight on 10x Genomics, Raises Price Target to $40Benzinga · Aug 7, 2026, 6:18 PM
Precision Medicine Collaboration and Licensing Deals 2019-2026 | Gain Access to Over 1,350 Deals and Benchmark with ConfidenceGlobenewswire Inc · Aug 7, 2026, 11:00 AM
10x Genomics Raises FY2026 Sales Guidance from $600.000M-$625.000M to $610.000M-$630.000M vs $613.851M EstBenzinga · Aug 6, 2026, 8:07 PM
10x Genomics Q2 EPS $(0.14) Beats $(0.24) Estimate, Sales $151.000M Beat $146.788M EstimateBenzinga · Aug 6, 2026, 8:05 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock